Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M2,403Revenue $M778Net Margin (%)13.2Altman Z-Score14.9
Enterprise Value $M2,269EPS $2.3Operating Margin %21.0Piotroski F-Score5
P/E(ttm)27.6Beneish M-Score-2.6Pre-tax Margin (%)21.0Higher ROA y-yN
Price/Book3.810-y EBITDA Growth Rate %--Quick Ratio3.8Cash flow > EarningsY
Price/Sales3.65-y EBITDA Growth Rate %22.7Current Ratio4.2Lower Leverage y-yY
Price/Free Cash Flow25.3y-y EBITDA Growth Rate %-38.2ROA % (ttm)11.9Higher Current Ratio y-yN
Dividend Yield %--PEG1.2ROE % (ttm)13.5Less Shares Outstanding y-yY
Payout Ratio %--Shares Outstanding M69.5ROIC % (ttm)17.8Gross Margin Increase y-yN

Gurus Latest Trades with MYGN

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
MYGNJoel Greenblatt 2015-03-31 Sold Out -0.16%$32.63 - $39.49
($35.79)
$ 34.60-3%Sold Out0
MYGNMario Gabelli 2015-03-31 Buy $32.63 - $39.49
($35.79)
$ 34.60-3%New holding25,000
MYGNKen Fisher 2015-03-31 Reduce$32.63 - $39.49
($35.79)
$ 34.60-3%Reduce 0.32%88,050
MYGNJoel Greenblatt 2014-12-31 Reduce-0.11%$32.01 - $39.49
($35.44)
$ 34.60-2%Reduce 34.58%568,865
MYGNKen Fisher 2014-12-31 Buy 0.01%$32.01 - $39.48
($35.39)
$ 34.60-2%New holding88,333
MYGNJoel Greenblatt 2014-09-30 Reduce-0.12%$35.44 - $40.41
($37.28)
$ 34.60-7%Reduce 22.18%869,531
MYGNFirst Eagle Investment 2014-06-30 Sold Out -0.03%$33.1 - $42.21
($37.18)
$ 34.60-7%Sold Out0
MYGNThird Avenue Management 2014-03-31 Sold Out -0.13%$20.79 - $38.17
($30.6)
$ 34.6013%Sold Out0
MYGNFirst Eagle Investment 2014-03-31 Buy 0.03%$20.79 - $38.17
($30.6)
$ 34.6013%New holding284,826
MYGNRonald Muhlenkamp 2013-12-31 Sold Out -2.3%$20.79 - $30.65
($25.36)
$ 34.6036%Sold Out0
MYGNJoel Greenblatt 2013-12-31 Add0.18%$20.79 - $30.65
($25.36)
$ 34.6036%Add 36.27%1,316,314
MYGNThird Avenue Management 2013-12-31 Buy 0.13%$20.79 - $30.65
($25.36)
$ 34.6036%New holding328,314
MYGNJoel Greenblatt 2013-09-30 Add0.32%$24.396 - $31.8
($28.51)
$ 34.6021%Add 74.78%965,987
MYGNRonald Muhlenkamp 2013-06-30 Buy 2.7%$24.35 - $34.26
($28.98)
$ 34.6019%New holding481,900
MYGNRon Baron 2013-06-30 Sold Out -0.09%$24.35 - $34.26
($28.98)
$ 34.6019%Sold Out0
MYGNJoel Greenblatt 2013-03-31 Add0.24%$24.19 - $27.68
($25.95)
$ 34.6033%Add 62.99%489,388
MYGNRon Baron 2013-03-31 Buy 0.09%$24.19 - $27.68
($25.95)
$ 34.6033%New holding658,653
MYGNJoel Greenblatt 2012-03-31 Add0.22%$20.36 - $25.64
($21.82)
$ 34.6059%Add 40.27%363,079
MYGNJoel Greenblatt 2011-12-31 Add0.11%$18.25 - $21.76
($20.37)
$ 34.6070%Add 21.40%258,844
MYGNJoel Greenblatt 2011-09-30 Add0.1%$17.86 - $23.86
($20.44)
$ 34.6069%Add 17.12%213,215
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

MYGN is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


MYGN: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
King Gary A.Exec. VP International Ops 2014-11-03Sell6,568$39.95-13.39view
Evans James SCFO 2014-09-30Sell21,850$38.99-11.26view
Evans James SCFO 2014-09-24Sell8,790$37.98-8.9view
Evans James SCFO 2014-09-23Sell110,463$37.89-8.68view
MELDRUM PETER DPresident & C.E.O. 2014-07-14Sell24,000$39.5-12.41view
LANCHBURY JERRY SChief Scientific Officer 2014-07-14Sell20,000$39.85-13.17view
HENDERSON JOHN TDirector 2014-06-05Sell5,000$35.7-3.08view
Rogers Ronald S.Exec VP Corp Communications 2014-05-09Sell12,500$36.01-3.92view
MARSH RICHARD ME.V.P., General Counsel 2014-04-30Sell30,000$41.8-17.22view
MARSH RICHARD ME.V.P., General Counsel 2014-04-23Sell31,516$39.8-13.07view

Press Releases about MYGN :

    Quarterly/Annual Reports about MYGN:

    News about MYGN:

    Articles On GuruFocus.com
    Chuck Royce Comments on Myriad Genetics Oct 08 2014 
    Chuck Royce’s Royce Premier Fund Second Quarter 2014 Manager Commentary Oct 08 2014 
    Why I Bought Myriad Genetics (MYGN) Apr 28 2014 
    Scott Black, Delphi Management Recommends Stocks Nov 19 2013 
    Surfing for Billionaire Bargains Sep 22 2013 
    Baron Funds Comments on Myriad Genetics Inc. Jun 06 2013 
    RS Investments' Value Fund First Quarter 2012 Mutual Fund Commentary Apr 17 2012 
    Chuck Royce Buys Hawkins Inc., Myriad Genetics, and Fairchild Semiconductor Jul 07 2011 
    Myriad Genetics Inc. Reports Operating Results (10-Q) May 05 2010 
    Myriad Genetics Inc. (MYGN) CFO James S Evans sells 8,400 Shares Mar 12 2010 

    More From Other Websites
    Myriad Validates Active Surveillance Threshold With Prolaris(R) for Men With Prostate Cancer May 15 2015
    Myriad Validates Active Surveillance Threshold With Prolaris(R) for Men With Prostate Cancer May 15 2015
    Myriad Showcases Its Pioneering Research at the 2015 ASCO Annual Meeting May 13 2015
    Myriad Showcases Its Pioneering Research at the 2015 ASCO Annual Meeting May 13 2015
    Myriad Genetics Q3 Test Growth Impresses Yet Revenues Fall - Analyst Blog May 11 2015
    10-Q for Myriad Genetics, Inc. May 08 2015
    Myriad to Present New Clinical Data on Prolaris(R) at the AUA 2015 Annual Meeting May 07 2015
    Myriad to Present New Clinical Data on Prolaris(R) at the AUA 2015 Annual Meeting May 07 2015
    Myriad Genetics Posts In-Line Q3 Earnings, Guides Lower - Analyst Blog May 06 2015
    MYRIAD GENETICS INC Files SEC form 10-Q, Quarterly Report May 06 2015
    Myriad Genetics Reports Fiscal Third-Quarter 2015 Financial Results May 05 2015
    Myriad meets 3Q profit forecasts May 05 2015
    Myriad meets 3Q profit forecasts May 05 2015
    Myriad Genetics Inc Earnings Call scheduled for 4:30 pm ET today May 05 2015
    MYRIAD GENETICS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial... May 05 2015
    Myriad Genetics Reports Fiscal Third-Quarter 2015 Financial Results May 05 2015
    Q3 2015 Myriad Genetics Inc Earnings Release - After Market Close May 05 2015
    PDF 11.91 KB May 04 2015
    Myriad Genetics Fights Off Threats From Rivals May 03 2015
    11 Buyout Targets Credit Suisse Is Watching Apr 29 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    Antoniy
    ReplyAntoniy - 1 year ago
    hs
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK